tiprankstipranks
Trending News
More News >
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market

Tempest Therapeutics (TPST) Income Statement

Compare
1,248 Followers

Tempest Therapeutics Income Statement

Last quarter (Q1 2025), Tempest Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Tempest Therapeutics's net income was $-10.86M. See Tempest Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -381.00K$ -1.81M$ -1.27M$ -815.00K
Operating Expenses
$ 42.03M$ 28.78M$ 34.64M$ 26.99M$ 19.30M
Depreciation and Amortization
$ 389.00K$ 381.00K$ 1.81M$ 1.27M$ 815.00K
EBITDA
$ -40.14M$ -28.78M$ -32.28M$ -25.72M$ -18.39M
Operating Income
$ -42.03M$ -29.16M$ -34.64M$ -26.99M$ -19.30M
Other Income/Expenses
$ 183.00K$ -334.00K$ -1.07M$ -1.32M$ 90.00K
Pretax Income
$ -41.84M$ -29.49M$ -35.71M$ -28.30M$ -19.21M
Net Income
$ -41.84M$ -29.49M$ -36.78M$ -29.55M$ -19.12M
Per Share Metrics
Basic EPS
$ -1.50$ -1.91$ -3.18$ -7.80$ -612.56
Diluted EPS
$ -1.50$ -1.91$ -3.18$ -7.80$ -612.56
Weighted Average Shares Outstanding
27.90M 15.42M 11.55M 3.79M 31.21K
Weighted Average Shares Outstanding (Diluted)
27.90M 15.42M 11.55M 3.79M 31.21K
Currency in USD

Tempest Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis